Works matching IS 02646021 AND DT 2022 AND VI 479 AND IP 9

Results: 5
    1
    2
    3
    4

    Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo.

    Published in:
    Biochemical Journal, 2022, v. 479, n. 9, p. 1007, doi. 10.1042/BCJ20220054
    By:
    • Wymann, Sandra;
    • Mischnik, Marcel;
    • Leong, David;
    • Ghosh, Subhajit;
    • Xiahui Tan;
    • Helen Cao;
    • Kuehnemuth, Benjamin;
    • Powers, Glenn A.;
    • Halder, Partho;
    • de Souza, Mitchell J.;
    • James, Hannah S.;
    • Tomasetig, Vesna;
    • Lind, Holger;
    • Rossato, Paolo;
    • Owczarek, Catherine M.;
    • Saw Yen Ow;
    • Dower, Steven K.;
    • Morelli, Adriana Baz;
    • Rowe, Tony;
    • Hardy, Matthew P.
    Publication type:
    Article
    5